ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4

Li, Kaishu; Huang, Guanglong; Wang, Ziyu; Yang, Runwei; Zhang, Wanghao; Ni, Bowen; Guan, Jingyu; Yi, Guozhong; Li, Zhiyong; Zhu, Qihui; Peng, Qian; Yang, Lunhao; Qi, Ling*; Liu, Yawei*广州医学院; 南方医科大学; 6
Biochimica et Biophysica Acta - Molecular Basis of Disease2023-1-1DOI: 10.1016/j.bbadis.2022.166571
3被引14阅读
引用收藏
分享

摘要

Sustained proliferative signaling is a crucial hallmark and therapeutic target in glioblastoma (GBM); however, new intrinsic regulators and their underlying mechanisms remain to be elucidated. In this study, I kappa B kinase interacting protein (IKBIP) was identified to be correlated with the progression of GBM by analysis of The Cancer Genome Atlas (TCGA) data. TCGA database analysis indicated that higher IKBIP expression was associated with high tumor grade and poor prognosis in GBM patients, and these correlations were subsequently validated in clinical samples. IKBIP knockdown induced G1/S arrest by blocking the Cyclin D1/CDK4/CDK6/CDK2 pathway. Our results showed that IKBIP may bind directly to CDK4, a key cell cycle checkpoint protein, and prevent its ubiquitination-mediated degradation in GBM cells. An in vivo study confirmed that IKBIP knockdown strongly suppressed cell proliferation and tumor growth and prolonged survival in a mouse xenograft model established with human GBM cells. In conclusion, IKBIP functions as a novel driver of GBM by binding and stabilizing the CDK4 protein. IKBIP could be a potential therapeutic target in GBM.

学科与关键词

关键词
GlioblastomaIKBIPCDK4Cell cycleUbiquitination
相关
加载中…
  • IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-kappa B
    Guan Hongyu; Zhang Heng; Cai Junchao; Wu Jueheng; Yuan Jie; Li Jun; Huang Zhengsong; Li Mengfeng*Journal of Pathology, 2011, 223(3): 436-445.被引 20
  • TUBA1A licenses APC/C-mediated mitotic progression to drive glioblastoma growth by inhibiting PLK3
    Wen, Jiaqi; Wang, Qiuke; Zhang, Wenyi; Wang, Weizhang*the and of llh 2019 for、with、to\ of the 、 or the\the、or、of d &、&、希基准, 2023, 597(24): 3072-3086.
  • PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B
    Wang, Ji; Xiao, Zongyu; Li, Peng; Wu, Chunwang; Li, Yan; Wang, Qing; Chen, Yanming; Zhou, Honglong; Li, Zhi; Wang, Zhaotao*; Lan, Qing*; Wang, Yezhong*Oncogene, 2023, 42(14): 1088-1100.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Biochimica et Biophysica Acta - Molecular Basis of Disease
发表日期
2023-01-01
卷期
第 1869 卷, 第 1 期
页码
166571
DOI
10.1016/j.bbadis.2022.166571
语言
DUTCH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773290, 81802505]; Key R&D Program of Guangdong Province [2018B090906001]; Natural Science Foundation of Guangdong Province [2021A1515012240, 2022A1515012552]; Medical Scientific Research Foundation of Guangdong Province [A2022125]; Guangdong Basic and Applied Basic Research Foundation [2021A1515010716]; Outstanding Youth Development Scheme of Nanfang Hospital, Southern Medical University [2019J002]; Medical Research Fund of Qingyuan People's Hospital [15001019002213]

作者

  • L

    Li, Kaishu (第一作者)

    southern med univ · 6 · guangzhou med univ

  • H

    Huang, Guanglong

    southern med univ

查看全部 14 位作者收起作者
  • W

    Wang, Ziyu

    southern med univ

  • Y

    Yang, Runwei

    southern med univ

  • Z

    Zhang, Wanghao

    southern med univ

  • N

    Ni, Bowen

    southern med univ

  • G

    Guan, Jingyu

    6 · guangzhou med univ

  • Y

    Yi, Guozhong

    southern med univ

  • L

    Li, Zhiyong

    southern med univ

  • Z

    Zhu, Qihui

    6 · guangzhou med univ

  • P

    Peng, Qian

    6 · guangzhou med univ

  • Y

    Yang, Lunhao

    6 · guangzhou med univ

  • Q

    Qi, Ling (通讯)

    6 · guangzhou med univ

  • L

    Liu, Yawei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417